Syncell

About:

Syncell is a proteomics technology company enabling in situ protein drug target discovery.

Website: https://syncell.com

Top Investors: Darwin Venture Management

Description:

Syncell is a proteomics technology company enabling disease site-specific protein drug target discovery. Its pioneering Microscoop™ technology enables microscopy-guided nanoscale protein "scooping", making unbiased subcellular spatial proteomic discovery feasible for the first time. This technology can be applied to a broad range of biological problems to help identify novel disease biomarkers and reveal novel druggable targets.